Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Y
Yamamoto, Kasumi
Department of Medical Oncology, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Kasumi Yamamoto
Favorite
Yamamoto, Noboru
Department of Experimental Therapeutics, National Cancer Center Hospital
(
P 163
)
PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MURINE DOUBLE MINUTE 2–TUMOR PROTEIN 53 ANTAGONIST BI 907828 IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH ADVANCED SOLID TUMORS
Noboru Yamamoto
Favorite
Yamashita, Toshihiko
Sapporo Medical University School of Medicine
(
P 084
)
PROGNOSTIC FACTORS IN PATIENTS WITH DISTANT SOFT TISSUE METASTASIS OF CARCINOMA
Toshihiko Yamashita
Favorite
(
P 285
)
IMPACT OF ACRIDINE ORANGE IN PATIENTS WITH LOCAL RECURRENT SOFT TISSUE SARCOMA
Toshihiko Yamashita
Favorite
Yanagawa, Jane
UCLA
(
P 039
)
THE GENOMIC AND IMMUNE LANDSCAPE OF OSTEOSARCOMA
Jane Yanagawa
Favorite
(
P 183
)
OSTEOSARCOMA ORGANOIDS RECAPITULATE TUMOR CHARACTERISTICS AND MAINTAIN HETEROGENEITY
Jane Yanagawa
Favorite
(
P 184
)
PAN-SARCOMA ORGANOID SCREENING PIPELINE
Jane Yanagawa
Favorite
(
P 310
)
TUMOR REVIEW BOARD FOR OSTEOSARCOMA (TURBO): BIMONTHLY, MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR OSTEOSARCOMA
Jane Yanagawa
Favorite
Yang, Kyung-Min
Medpacto, Inc
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
Kyung-Min Yang
Favorite
Yang, Mary
University of Texas Southwestern Medical Center
(
P 104
)
INFANTILE EXTRARENAL SPINDLE CELL MESENCHYMAL NEOPLASMS WITH TARGETABLE EGFR KINASE DOMAIN DUPLICATIONS
Mary Yang
Favorite
Yang, Valerie
National Cancer Centre Singapore
(
P 090
)
TEN-YEAR INCIDENCE AND MORTALITY OF SOFT TISSUE SARCOMAS IN THE NATIONAL CANCER CENTRE SINGAPORE, FROM 2012 TO 2021
Valerie Yang
Favorite
(
P 196
)
THERAPEUTIC VULNERABILITY AND RESISTANCE DURING PROGRESSION OF AN AGGRESSIVE SOLITARY FIBROUS TUMOUR
Valerie Yang
Favorite
Yan, Wei
University of Michigan
(
P 139
)
T-CELL PROFILING IN HIGH GRADE SARCOMAS
Wei Yan
Favorite
Yao, Lan
Department of Anesthesiology, Peking University International Hospital
(
P 211
)
ANESTHESIA MANAGEMENTS AND POSTOPERATIVE MORTALITIES IN RETROPERITONEAL SARCOMA PATIENTS EXPERIENCING MASSIVE BLOOD TRANSFUSION DURING SURGERIES
Lan Yao
Favorite
Yao, Weitao
Department of Orthopedics, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Weitao Yao
Favorite
Yazaki, Shu
Department of Medical Oncology, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Shu Yazaki
Favorite
(
P 150
)
CLINICAL CHARACTERISTICS OF PRIMARY CUTANEOUS AND SUBCUTANEOUS EWING SARCOMA FAMILY OF TUMORS
Shu Yazaki
Favorite
Yechieli, Rafael
Sylvester Comprehensive Cancer Center
(
P 070
)
COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT TREATMENT IN SOFT TISSUE SARCOMA. A SINGLE INSTITUTION EXPERIENCE.
Rafael Yechieli
Favorite
Yellapantula, Venkata
Children's Hospital Los Angeles
(
P 045
)
DETECTION OF CELL-FREE TUMOR DNA IN PATIENTS WITH NEWLY DIAGNOSED PEDIATRIC BONE AND SOFT TISSUE SARCOMAS
Venkata Yellapantula
Favorite
Yeo, Kee Kiat
Dana-Farber Cancer Institute
(
P 239
)
FGFR IS A RELEVANT MOLECULAR TARGET IN PEDIATRIC AND AYA SARCOMAS
Kee Kiat Yeo
Favorite
Yeo, Sarah
University of British Columbia
(
P 074
)
EWING SARCOMA AND RHABDOMYOSARCOMA PATIENT OUTCOME VARIATIONS BASED ON TREATMENT CENTRE VOLUME
Sarah Yeo
Favorite
Yevich, Steven
MD Anderson Cancer Center
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
Steven Yevich
Favorite
Ye, Xin
Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
(
P 038
)
TENOSYNOVIAL GIANT CELL TUMOR OBSERVATIONAL PLATFORM PROJECT (TOPP): 2-YEAR OBSERVATIONAL SUB-ANALYSIS OF AGE AND PATIENT-REPORTED OUTCOMES FROM AN EU/US PROSPECTIVE REGISTRY
Xin Ye
Favorite
(
P 066
)
CHARACTERISTICS OF PATIENTS RECEIVING PEXIDARTINIB IN THE REAL-WORLD SETTING: A CROSS-SECTIONAL SURVEY
Xin Ye
Favorite
Ye, Zhaoming
Department of Orthopedics, the Second Affiliated Hospital of Zhejiang University School of Medicine
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Zhaoming Ye
Favorite
Yih, Chun Ling Patricia
Department of Surgery, Prince of Wales Hospital
(
P 210
)
A LONGITUDINAL ANALYSIS OF PROGNOSTIC FACTORS IN CHINESE PATIENTS WITH RETROPERITONEAL LIPOSARCOMA
Chun Ling Patricia Yih
Favorite
Yin, Peng
Wyss Institute for Biologically Inspired Engineering, Harvard University
(
P 099
)
CONCURRENT INHIBITION OF CDK2 ADDS TO THE ANTI-TUMOR ACTIVITY OF CDK4/6 INHIBITION IN GIST
Peng Yin
Favorite
Yin, Yongmei
Department of Oncology, The First Affiliated Hospital of Nanjing Medical University
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Yongmei Yin
Favorite
Yi, Thomas
Rush University Medical Center
(
P 081
)
MISSING DATA IN THE DEVELOPMENT AND EXTERNAL VALIDATION OF MACHINE LEARNING MODELS FOR SURVIVAL PREDICTION IN SARCOMA
Thomas Yi
Favorite
Yonemori, Kan
Department of Medical Oncology, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Kan Yonemori
Favorite
(
P 150
)
CLINICAL CHARACTERISTICS OF PRIMARY CUTANEOUS AND SUBCUTANEOUS EWING SARCOMA FAMILY OF TUMORS
Kan Yonemori
Favorite
Yoon, Hong In
Yonsei University College of Medicine
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
Hong In Yoon
Favorite
Yoshida, Akihiko
Department of Diagnostic Pathology, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Akihiko Yoshida
Favorite
(
P 150
)
CLINICAL CHARACTERISTICS OF PRIMARY CUTANEOUS AND SUBCUTANEOUS EWING SARCOMA FAMILY OF TUMORS
Akihiko Yoshida
Favorite
Yoshida, Shinichirou
Tohoku University School of Medicine
(
P 091
)
THE PROGNOSIS OF PULMONARY METASTASIS AFTER THE SURGERY FOR PRIMARY LESION IN ELDERLY HIGH-GRADE SARCOMA PATIENTS
Shinichirou Yoshida
Favorite
Yoshida, Shinichirou
Department of Orthopaedic Surgery Tohoku University Graduate School of Medicine
(
P 209
)
THE OUTCOME OF R1 EXCISION COMBINED WITH ADJUVANT RADIOTHERAPY FOR SOFT TISSUE SARCOMA IN ELDERLY PATIENTS
Shinichirou Yoshida
Favorite
Younesi, Elan
Sarcoma Oncology Research Center
(
P 137
)
SAINT: FIVE YEAR RESULTS OF A PHASE 2 TRIAL USING IPILIMUMAB (I), NIVOLUMAB (N) AND TRABECTEDIN (T) FOR PREVIOUSLY UNTREATED ADVANCED SOFT TISSUE SARCOMA [NCT03138161]
Elan Younesi
Favorite
(
P 138
)
SUSTAINED REMISSION/DISEASE CONTROL USING AUTOLOGOUS ENHANCED NATURAL KILLER CELLS PLUS AN IMMUNE CHECKPOINT INHIBITOR AS TREATMENT FOR RARE CHEMOTHERAPY-RESISTANT ADVANCED SOFT TISSUE SARCOMAS
Elan Younesi
Favorite
Young, Courtney
Indiana University
(
P 192
)
TARGETING PI3K/MTOR MITIGATES RESISTANCE TO CDK4/6 INHIBITION IN RB-PROFICIENT PEDIATRIC AND AYA OSTEOSARCOMAS
Courtney Young
Favorite
Younger, Eugenie
2. Sarcoma Unit, Royal Marsden NHS Foundation Trust, London
(
P 319
)
PATIENT REPORTED OUTCOME ASSESSMENT AND REPORTING IN RANDOMIZED CLINICAL TRIALS OF SYSTEMIC THERAPY FOR ADVANCED SOFT TISSUE SARCOMAS; PROTOCOL FOR A SYSTEMATIC REVIEW
Eugenie Younger
Favorite
Yovell, Jonathan
Ayala Pharmaceuticals
(
P 268
)
INITIAL RESULTS OF PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS (DT)
Jonathan Yovell
Favorite
Yuan, Ting
Department of Orthopedics,Shanghai Jiao Tong University Affiliated Sixth People's Hospital
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Ting Yuan
Favorite
Yun, Kum-Hee
yonsei university
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
Kum-Hee Yun
Favorite
Back to Top
